128 related articles for article (PubMed ID: 11493098)
1. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial.
Weinstock MA; Bingham SF; Cole GW; Eilers D; Naylor MF; Kalivas J; Taylor JR; Gladstone HB; Piacquadio DJ; DiGiovanna JJ
Arch Dermatol; 2001 Aug; 137(8):1055-8. PubMed ID: 11493098
[TBL] [Abstract][Full Text] [Related]
2. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
[TBL] [Abstract][Full Text] [Related]
3. Improvement in precision of counting actinic keratoses.
Lee KC; Lew R; Weinstock MA
Br J Dermatol; 2014 Jan; 170(1):188-91. PubMed ID: 24102420
[TBL] [Abstract][Full Text] [Related]
4. Facial resurfacing for nonmelanoma skin cancer prophylaxis.
Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM
Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
6. Reliability of the histopathologic diagnosis of keratinocyte carcinomas.
Jagdeo J; Weinstock MA; Piepkorn M; Bingham SF;
J Am Acad Dermatol; 2007 Aug; 57(2):279-84. PubMed ID: 17482716
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.
Weinstock MA; Lee KC; Chren MM; Marcolivio K;
J Am Acad Dermatol; 2009 Aug; 61(2):207-15. PubMed ID: 19398145
[TBL] [Abstract][Full Text] [Related]
8. Laser-mediated photodynamic therapy of actinic keratoses.
Alexiades-Armenakas MR; Geronemus RG
Arch Dermatol; 2003 Oct; 139(10):1313-20. PubMed ID: 14568836
[TBL] [Abstract][Full Text] [Related]
9. Prospective quality of life impact of actinic keratoses: observations from the veterans affairs topical tretinoin chemoprevention trial.
Lee K; Weinstock M
Acta Derm Venereol; 2011 Jan; 91(1):101-2. PubMed ID: 21103828
[No Abstract] [Full Text] [Related]
10. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
11. Topical tretinoin therapy and all-cause mortality.
Weinstock MA; Bingham SF; Lew RA; Hall R; Eilers D; Kirsner R; Naylor M; Kalivas J; Cole G; Marcolivio K; Collins J; Digiovanna JJ; Vertrees JE;
Arch Dermatol; 2009 Jan; 145(1):18-24. PubMed ID: 19153339
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin.
Butler GJ; Neale R; Green AC; Pandeya N; Whiteman DC
J Am Acad Dermatol; 2005 Dec; 53(6):966-72. PubMed ID: 16310056
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
[TBL] [Abstract][Full Text] [Related]
14. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
[TBL] [Abstract][Full Text] [Related]
15. Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial.
Dyer RK; Weinstock MA; Cohen TS; Rizzo AE; Bingham SF;
J Invest Dermatol; 2012 Nov; 132(11):2544-51. PubMed ID: 22810303
[TBL] [Abstract][Full Text] [Related]
16. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study.
Balkrishnan R; Cayce KA; Kulkarni AS; Orsagh T; Gallagher JR; Richmond D; Feldman SR
J Dermatolog Treat; 2006; 17(3):162-6. PubMed ID: 16854758
[TBL] [Abstract][Full Text] [Related]
17. Differences in biopsy techniques of actinic keratoses by plastic surgeons and dermatologists: a histologically controlled pilot study.
Sellheyer K; Bergfeld WF
Arch Dermatol; 2006 Apr; 142(4):455-9. PubMed ID: 16618864
[TBL] [Abstract][Full Text] [Related]
18. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
Beatson M; Siegel JA; Chren MM; Weinstock MA
Eur J Dermatol; 2019 Oct; 29(5):507-510. PubMed ID: 31647464
[TBL] [Abstract][Full Text] [Related]
19. Topical tretinoin in actinic keratosis and basal cell carcinoma.
Peck GL
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):829-35. PubMed ID: 3534022
[TBL] [Abstract][Full Text] [Related]
20. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.
Weinstock MA; Bingham SF; Digiovanna JJ; Rizzo AE; Marcolivio K; Hall R; Eilers D; Naylor M; Kirsner R; Kalivas J; Cole G; Vertrees JE;
J Invest Dermatol; 2012 Jun; 132(6):1583-90. PubMed ID: 22318383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
